Polymorphism of FGFR4 in cancer development and sensitivity to cisplatin and radiation in head and neck cancer

Oral Oncology

Volumn 45, Issue 1, 2009, Pages 23-29

  Ansell, Anna ^a   Farnebo, Lovisa ^a   Grénman, Reidar ^c   Roberg, Karin ^a   Thunell, Lena K ^b  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

Chemotherapy; Oral tumours; Radiotherapy

Indexed keywords

ARGININE; CISPLATIN; FIBROBLAST GROWTH FACTOR RECEPTOR 4; GLYCINE;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIVITY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA; TUMOR BIOPSY;

ADULT; AGED; ALLELES; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CISPLATIN; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RADIATION TOLERANCE; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 4; TUMOR CELLS, CULTURED; YOUNG ADULT;

EID: 57549110120     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2008.03.007     Document Type: Article

References (25)

1. Shah J.P., and Lydiatt W. Treatment of cancer of the head and neck. CA Cancer J Clin 45 (1995) 352-368
2. Friedman N.R. Prognostic factors for local recurrence, metastases, and survival rates in squamous cell carcinoma of the skin, ear, and lip. J Am Acad Dermatol 28 (1993) 281-282
3. Powers C.J., McLeskey S.W., and Wellstein A. Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer 7 (2000) 165-197
4. Meyers G.A., Orlow S.J., Munro I.R., Przylepa K.A., and Jabs E.W. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nat Genet 11 (1995) 462-464
5. Shiang R., Thompson L.M., Zhu Y.Z., et al. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78 (1994) 335-342
6. 388 allele correlates with survival in head and neck squamous cell carcinoma. Exp Mol Pathol 82 (2007) 53-57
7. Bange J., Prechtl D., Cheburkin Y., et al. Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele. Cancer Res 62 (2002) 840-847
8. Wang J., Stockton D.W., and Ittmann M. The fibroblast growth factor receptor-4 Arg388 allele is associated with prostate cancer initiation and progression. Clin Cancer Res 10 (2004) 6169-6178
9. Streit S., Bange J., Fichtner A., Ihrler S., Issing W., and Ullrich A. Involvement of the FGFR4 Arg388 allele in head and neck squamous cell carcinoma. Int J Cancer 111 (2004) 213-217
10. Morimoto Y., Ozaki T., Ouchida M., et al. Single nucleotide polymorphism in fibroblast growth factor receptor 4 at codon 388 is associated with prognosis in high-grade soft tissue sarcoma. Cancer 98 (2003) 2245-2250
11. Mawrin C., Kirches E., Diete S., et al. Analysis of a single nucleotide polymorphism in codon 388 of the FGFR4 gene in malignant gliomas. Cancer Lett 239 (2006) 239-245
12. Spinola M., Leoni V.P., Tanuma J., et al. FGFR4 Gly388Arg polymorphism and prognosis of breast and colorectal cancer. Oncol Rep 14 (2005) 415-419
13. Matakidou A., El Galta R., Rudd M.F., et al. Further observations on the relationship between the FGFR4 Gly388Arg polymorphism and lung cancer prognosis. Br J Cancer 96 (2007) 1904-1907
14. Nilsson J.A., Hedberg J.J., Vondracek M., et al. Alcohol dehydrogenase 3 transcription associates with proliferation of human oral keratinocytes. Cell Mol Life Sci 61 (2004) 610-617
15. Grenman R., Carey T.E., McClatchey K.D., et al. In vitro radiation resistance among cell lines established from patients with squamous cell carcinoma of the head and neck. Cancer 67 (1991) 2741-2747
16. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
17. Thussbas C., Nahrig J., Streit S., et al. FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer. J Clin Oncol 24 (2006) 3747-3755
18. Elander N., Soderkvist P., and Fransen K. Matrix metalloproteinase (MMP) -1, -2, -3 and -9 promoter polymorphisms in colorectal cancer. Anticancer Res 26 (2006) 791-795
19. Hettiaratchi A., Hawkins N.J., McKenzie G., et al. The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancer. Br J Cancer 96 (2007) 783-792
20. Bradford C.R., Zhu S., Ogawa H., et al. P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines. Head Neck 25 (2003) 654-661
21. Couture C., Raybaud-Diogene H., Tetu B., et al. p53 and Ki-67 as markers of radioresistance in head and neck carcinoma. Cancer 94 (2002) 713-722
22. Mandic R., Schamberger C.J., Muller J.F., et al. Reduced cisplatin sensitivity of head and neck squamous cell carcinoma cell lines correlates with mutations affecting the COOH-terminal nuclear localization signal of p53. Clin Cancer Res 11 (2005) 6845-6852
23. Noutomi T., Chiba H., Itoh M., Toyota H., and Mizuguchi J. Bcl-x(L) confers multi-drug resistance in several squamous cell carcinoma cell lines. Oral Oncol 38 (2002) 41-48
24. Pekkola-Heino K., Jaakkola M., Kulmala J., and Grenman R. Comparison of cellular radiosensitivity between different localizations of head and neck squamous-cell carcinoma. J Cancer Res Clin Oncol 121 (1995) 452-456
25. Erjala K., Pulkkinen J., Kulmala J., and Grenman R. Concomitant vinorelbine and radiation in head and neck squamous cell carcinoma in vitro. Acta Oncol 43 (2004) 169-174